Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Karl P. Schillinger"'
Autor:
June A. Jones, Jessica L. Badders, Annette M. Jackson, Melissa E. Jeresano, Karl P. Schillinger
Publikováno v:
Human Immunology. 76:795-800
Flow cytometric crossmatch tests are used to detect donor-specific antibody and determine eligibility for transplantation. Crossmatch sensitivity is dependent on lymphocyte quality, to include HLA expression on the cell surface. The impact of HLA exp
Publikováno v:
Human Immunology. 80:69
Autor:
Andrew J. Eckstein, Renato M. Vega, Julie A. Houp, Karl P. Schillinger, Annette M. Jackson, Niraj M. Desai, Bonnie E. Lonze
Publikováno v:
Human immunology. 78(1)
The new kidney allocation system (KAS) provides additional allocation points for candidates with broad HLA sensitization in an effort to increase transplant rates for this underserved population. Following the implementation of KAS, our center lowere
Autor:
Andrea A. Zachary, Niraj M. Desai, Robert A. Montgomery, Mary Jo Holechek, Dorry L. Segev, Andrew L. Singer, Nada Alachkar, Bonnie E. Lonze, Andrew M. Cameron, Karl P. Schillinger, Nabil N. Dagher
Publikováno v:
Transplantation. 94:165-171
Human leukocyte antigen (HLA) sensitization presents a major obstacle for patients awaiting renal transplantation. HLA antibody reduction and favorable transplantation rates have been reported after treatment with high-dose intravenous immunoglobulin
Publikováno v:
Human Immunology. 72:330-336
Pronase treatment of lymphocytes is used to reduce nonspecific binding of immunoglobulins in flow cytometric crossmatch (FCXM) tests and at higher concentrations to remove CD20 from the cell surface. We examined the effect of pronase treatment on hum
Autor:
Elizabeth M. Moore, Karl P. Schillinger, Melissa E. Jeresano, Donna P. Lucas, Annette M. Jackson
Publikováno v:
Human Immunology. 79:49
Aim We previously reported differences in HLA expression on lymphocytes isolated from different tissues and the impact tissue source can have on reactivity. In the current study, we re-examined HLA expression and the impact of lymphocyte enrichment u
Autor:
Annette M. Jackson, Donna P. Lucas, Mary Carmelle Philogene, Karl P. Schillinger, Melissa E. Jeresano
Publikováno v:
Human Immunology. 78:34
Aim Non-HLA antibody monitoring using endothelial crossmatch (XM-ONE®) and Angiotensin Type I Receptor (AT1R) antibody tests was performed to determine efficacy of therapeutic plasma exchange in the treatment of antibody mediated rejection (AMR) in
Publikováno v:
Human Immunology. 77:120
Aim The new Kidney Allocation System (KAS) provides additional allocation points for sensitized candidates in an effort to increase transplant rates for this underserved population Following the implementation of KAS, our center lowered the HLA antib
Publikováno v:
Human Immunology. 77:115
Introduction Experienced personnel are a laboratory’s greatest asset. Several management strategies have been applied over the years to retain staff including a 5 tier promotion structure, salary adjustments, professional development, meeting atten
Publikováno v:
Human Immunology. 76:117
The algorithm for determining CPRA values that incorporate two or more of the HLA-A, -B, -C, -DRB1, -DRB3-5, -DQA, and -DQB loci requires information about the frequencies of alleles at the various loci as well as of the haplotypes comprised of the l